The global artificial intelligence (AI) leader Insilico Medicine announced its first milestone in cancer immunotherapy for their external collaboration with …
Getting a step closer to treating Idiopathic Pulmonary Fibrosis A Hong Kong-based company applying a state-of-the-art artificial intelligence (AI) platform …
A Hong Kong-based artificial intelligence (AI)-driven drug discovery company Insilico Medicine has just announced the appointment of Dr. Michelle Chen …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.